Dapagliflozin Lowers Plasma Glucose Concentration and Improves Beta Cell Function.
Phase of Trial: Phase II
Latest Information Update: 03 Nov 2015
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 03 Nov 2015 Status changed from not stated to completed.
- 03 Nov 2015 New trial record